Coexpression cluster:C232

Full id: C232_teratocarcinoma_HES3GFP_H9_iPS_testicular_neuroblastoma_cerebellum

Phase1 CAGE Peaks

Hg19::chr10:98161098..98161100,+	p@chr10:98161098..98161100 +
Hg19::chr11:122684227..122684231,+	p@chr11:122684227..122684231 +
Hg19::chr11:2022489..2022501,-	p37@H19
Hg19::chr11:41327517..41327518,+	p@chr11:41327517..41327518 +
Hg19::chr11:92850299..92850305,-	p@chr11:92850299..92850305 -
Hg19::chr12:68284590..68284597,-	p@chr12:68284590..68284597 -
Hg19::chr12:8034314..8034336,-	p@chr12:8034314..8034336 -
Hg19::chr13:102603275..102603278,+	p@chr13:102603275..102603278 +
Hg19::chr13:27914684..27914686,-	p@chr13:27914684..27914686 -
Hg19::chr13:44925859..44925864,+	p@chr13:44925859..44925864 +
Hg19::chr13:51747485..51747488,-	p@chr13:51747485..51747488 -
Hg19::chr14:98103699..98103702,-	p@chr14:98103699..98103702 -
Hg19::chr15:73150394..73150400,+	p@chr15:73150394..73150400 +
Hg19::chr15:79787932..79787937,-	p@chr15:79787932..79787937 -
Hg19::chr16:16064786..16064790,-	p@chr16:16064786..16064790 -
Hg19::chr1:10875488..10875494,+	p@chr1:10875488..10875494 +
Hg19::chr1:146544055..146544062,-	p@chr1:146544055..146544062 -
Hg19::chr1:38619558..38619563,+	p@chr1:38619558..38619563 +
Hg19::chr1:62661907..62661916,+	p@chr1:62661907..62661916 +
Hg19::chr1:62675663..62675671,-	p@chr1:62675663..62675671 -
Hg19::chr20:52685670..52685678,+	p@chr20:52685670..52685678 +
Hg19::chr2:168243434..168243438,+	p@chr2:168243434..168243438 +
Hg19::chr2:169769806..169769861,-	p2@SPC25
Hg19::chr2:202835658..202835677,+	p@chr2:202835658..202835677 +
Hg19::chr2:48919688..48919703,+	p@chr2:48919688..48919703 +
Hg19::chr2:48919725..48919761,+	p@chr2:48919725..48919761 +
Hg19::chr3:14658573..14658581,+	p@chr3:14658573..14658581 +
Hg19::chr3:186700341..186700345,+	p@chr3:186700341..186700345 +
Hg19::chr3:194646645..194646650,-	p@chr3:194646645..194646650 -
Hg19::chr3:32455724..32455728,-	p@chr3:32455724..32455728 -
Hg19::chr3:32904712..32904715,+	p@chr3:32904712..32904715 +
Hg19::chr3:32937906..32937913,+	p@chr3:32937906..32937913 +
Hg19::chr3:32938576..32938590,+	p@chr3:32938576..32938590 +
Hg19::chr4:113572878..113572895,-	p@chr4:113572878..113572895 -
Hg19::chr4:113628003..113628015,-	p1@ENST00000505632
Hg19::chr5:116157646..116157650,+	p@chr5:116157646..116157650 +
Hg19::chr5:118738398..118738400,+	p@chr5:118738398..118738400 +
Hg19::chr5:120034108..120034114,-	p@chr5:120034108..120034114 -
Hg19::chr5:122512045..122512049,+	p@chr5:122512045..122512049 +
Hg19::chr5:147253888..147253894,-	p@chr5:147253888..147253894 -
Hg19::chr5:81591218..81591231,+	p@chr5:81591218..81591231 +
Hg19::chr6:10417667..10417676,-	p54@TFAP2A
Hg19::chr7:148034419..148034425,+	p@chr7:148034419..148034425 +
Hg19::chr7:21120890..21120893,+	p@chr7:21120890..21120893 +
Hg19::chr7:24436189..24436212,+	p@chr7:24436189..24436212 +
Hg19::chr7:44263545..44263550,-	p@chr7:44263545..44263550 -
Hg19::chr7:66858115..66858118,+	p@chr7:66858115..66858118 +
Hg19::chr8:101973268..101973275,+	p@chr8:101973268..101973275 +
Hg19::chr8:38389009..38389020,+	p@chr8:38389009..38389020 +
Hg19::chr9:17536850..17536852,+	p@chr9:17536850..17536852 +
Hg19::chr9:5868313..5868316,+	p@chr9:5868313..5868316 +
Hg19::chr9:79633621..79633632,+	p2@FOXB2
Hg19::chr9:93653244..93653250,-	p@chr9:93653244..93653250 -
Hg19::chrX:136646431..136646476,+	p@chrX:136646431..136646476 +
Hg19::chrX:136648279..136648295,+	p1@ZIC3
Hg19::chrX:136648297..136648319,+	p3@ZIC3
Hg19::chrX:136648554..136648576,+	p4@ZIC3
Hg19::chrX:136650899..136650918,+	p7@ZIC3
Hg19::chrX:36968877..36968881,-	p@chrX:36968877..36968881 -
Hg19::chrX:97828862..97828879,+	p@chrX:97828862..97828879 +
Hg19::chrX:99848620..99848641,+	p5@TNMD

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n
neural cell	3.33e-08	25

Uber Anatomy

Ontology term	p-value	n
regional part of nervous system	1.87e-33	94
nervous system	1.87e-33	94
central nervous system	2.75e-33	82
brain	7.24e-27	69
future brain	7.24e-27	69
neural tube	2.92e-26	57
neural rod	2.92e-26	57
future spinal cord	2.92e-26	57
neural keel	2.92e-26	57
neurectoderm	4.79e-26	90
neural plate	5.68e-25	86
presumptive neural plate	5.68e-25	86
regional part of brain	1.63e-24	59
ectoderm	1.60e-23	173
presumptive ectoderm	1.60e-23	173
ectoderm-derived structure	1.91e-22	169
regional part of forebrain	3.24e-19	41
forebrain	3.24e-19	41
future forebrain	3.24e-19	41
pre-chordal neural plate	6.76e-19	61
anterior neural tube	4.00e-18	42
gray matter	3.11e-17	34
brain grey matter	3.11e-17	34
telencephalon	5.54e-17	34
head	7.09e-17	123
regional part of telencephalon	1.43e-16	33
cerebral hemisphere	4.10e-16	32
anterior region of body	1.83e-15	129
craniocervical region	1.83e-15	129
cerebral cortex	6.86e-13	25
pallium	6.86e-13	25
regional part of cerebral cortex	2.16e-11	22
neocortex	2.15e-10	20
organ part	9.59e-10	219
posterior neural tube	2.08e-09	15
chordal neural plate	2.08e-09	15
segmental subdivision of nervous system	7.93e-09	13
segmental subdivision of hindbrain	2.95e-08	12
hindbrain	2.95e-08	12
presumptive hindbrain	2.95e-08	12
cell layer	3.38e-07	312
regional part of metencephalon	8.43e-07	9
metencephalon	8.43e-07	9
future metencephalon	8.43e-07	9

Disease

Ontology term	p-value	n
cancer	1.13e-14	235
cell type cancer	4.66e-14	143
disease of cellular proliferation	2.87e-13	239
carcinoma	1.30e-10	106
germ cell and embryonal cancer	9.91e-08	22
germ cell cancer	9.91e-08	22

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF	#promoters	Enrichment	p-value	q-value
TAF7#6879	20	3.74854734587669	1.22287687352815e-07	7.02895089677525e-06

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.